Healthcare and Life Science
Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research
Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research. ...
eg technology publish case study on redesigning Endomag's Sentimag® surgical guidance system
Find out how eg technology worked with Endomag to develop the Sentimag® surgical guidance system designed to transform breast cancer care. ...
Professor Kai-Michael Toellner joins the Immunology programme as a senior group leader
Prof Kai-Michael Toellner is welcomed to the Institute as he joins the Institute as a senior group leader in the Immunology research programme. Prof. Toellner’s expertise in immune cell differentiation, antibody production and how long-term immune memory is formed is highly complementar...
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr. Frank F. Craig, current CEO and co-founder, announces his retirement after leading the Company for 14 years. ...
PlaqueTec closes $8 million equity financing
The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform the treatment of CAD Cambridge, UK, 30 April 2024: PlaqueTec, a company identifyi...
Communigage wins UK Enterprise Award
Here at Communigage, a messaging and employer brand strategy consulting firm for small and medium-sized enterprises (SMEs), we are thrilled to announce that we have been chosen as the winner of the 2024 SME News UK Enterprise Award for Best New SME Consulting Firm. This prestigious awar...
Global pharma companies’ return on R&D investment increases after record low
Projected return on innovation in pharma R&D in 2023 has risen to 4.1 per cent, indicating a potential recovery from the long term downward trend in R&D productivity; The top 20 global pharmaceutical companies spent $145 billion on R&D investments in 2022-23*; AI is yet to...
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated, enabling biomanufacturing scalability and a more robust production process. T...
Guardtech Group off to a stormer in 2024 as action-packed quarter one flies by
Haverhill-based cleanroom design & build experts are working on more than 20 significant projects concurrently – an all-time high ...
Registration open for our Scientific Conference in June
We are excited to announce that you can now secure your spot for the 2nd NIHR BioResource Scientific Conference, taking place online on Wednesday 19 June 2024 from 9.30am to 12.30pm. ...